UnknownNot Applicable

Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

100 participantsStarted 2023-12

Plain-language summary

Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * (1) age ≤ 45 years old, strong desire to preserve reproductive function, and no factors of reproductive dysfunction evaluated before treatment; (2) The pathological type is atypical endometrial hyperplasia or endometrial cancer; (3) Imaging examination confirmed that the tumor was localized to the endometrium; (4) There are follow-up conditions available.

What they're measuring

Complete remission rate

Timeframe: 6months

Trial details

NCT IDNCT06170684

SponsorBeijing Obstetrics and Gynecology Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-01

View on ClinicalTrials.gov More Atypical Endometrial Hyperplasia and Endometrial Cancer trials